Latest news
Loading news…
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.
Audentes Therapeutics was acquired by Astellas Pharma in 2019 for $3B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
112
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- San Francisco, California, United States
Acquisitions by Audentes Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Audentes Therapeutics
Member of the Board of Directors
Vice President, Corporate Development
Vice President, Global Market Access - Gene Therapy
112
professional contacts at Audentes Therapeutics
Contact execs at Audentes Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Audentes Therapeutics
Loading news…
FAQs about Audentes Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.